Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30724644 | 1.00 | GPR3 (0.30) | GPR3 | |
| Hydrochloric Acid SCHEMBL723185 | 0.87 | HTR2A (0.33) | — | |
| Hydrochloric Acid SCHEMBL60273 | 0.87 | HTR2A (0.33) | — | |
| Bromide SCHEMBL6910231 | 0.85 | HTR2A (0.36) | — | |
| Hydrochloric Acid SCHEMBL6909128 | 0.85 | HTR6 (0.33) | — | |
| Hydrochloric Acid SCHEMBL3371892 | 0.84 | NPC1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL6917310 | 0.84 | HTR6 (0.32) | — | |
| Bromide SCHEMBL6910531 | 0.84 | HTR2A (0.37) | — | |
| Fluoride Ion SCHEMBL1130679 | 0.84 | HTR2A (0.33) | — | |
| SCHEMBL5838450 | 0.84 | HTR2A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0615981-B1 | Supported catalyst system, its preparation and its use in olefin polymerisation | TARGOR GMBH (DE) | 1998-05-06 | — | — | EP | claimed |
| EP-0610852-B1 | Process for preparing cyclo-olefin polymers | HOECHST AG (DE) | 1997-05-07 | — | — | EP | claimed |
| US-5545829-A | Process for preparing cycloolefin copolymers | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-08-13 | — | — | US | claimed |
| US-5391789-A | Bridged, chiral metallocenes, processes for their preparation and their use as catalysts | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-02-21 | — | — | US | claimed |
| EP-2050771-B1 | FILM OR LAMINATE COMPRISING ETHYLENE RESIN OR ETHYLENE RESIN COMPOSITION | MITSUI CHEMICALS INC (JP) | 2020-07-15 | — | — | EP | disclosed |
| US-8785574-B2 | Bridged metallocene compound, olefin polymerization catalyst containing the same, and ethylene polymer obtained with the catalyst | MITSUI CHEMICALS, INC. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-20140114031-A1 | BRIDGED METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE SAME, AND ETHYLENE POLYMER OBTAINED WITH THE CATALYST | PRIME POLYMER CO., LTD. (JP) | 2014-04-24 | — | — | US | disclosed |
| EP-2218725-B1 | BRIDGED METALLOCENE OLEFIN POLYMERIZATION CATALYST AND ETHYLENE POLYMER OBTAINED BY USING THE CATALYST | MITSUI CHEMICALS INC (JP) | 2013-10-23 | — | — | EP | disclosed |
| US-8299193-B2 | Film or laminate comprising ethylene-based resin or ethylene-based resin composition | MITSUI CHEMICALS, INC. (JP) | 2012-10-30 | — | — | US | disclosed |
| US-7858723-B2 | Ethylene-based resin and molded object obtained therefrom | MITSUI CHEMICALS, INC. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20100292421-A1 | BRIDGED METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE SAME, AND ETHYLENE POLYMER OBTAINED WITH THE CATALYST | MITSUI CHEMICALS, INC. | 2010-11-18 | — | — | US | disclosed |
| EP-1849805-B1 | ETHYLENIC RESIN AND FORMED ARTICLE OBTAINED THEREFROM | MITSUI CHEMICALS INC (JP) | 2010-11-10 | — | — | EP | disclosed |
| EP-2218725-A1 | BRIDGED METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST USING THE COMPOUND AND ETHYLENE POLYMER OBTAINED BY USING THE CATALYST | Mitsui Chemicals, Inc. (JP) | 2010-08-18 | — | — | EP | disclosed |
| US-20090291285-A1 | FILM OR LAMINATE COMPRISING ETHYLENE-BASED RESIN OR ETHYLENE-BASED RESIN COMPOSITION | MITSUI CHEMICALS, INC. | 2009-11-26 | — | — | US | disclosed |
| EP-2050771-A1 | FILM OR LAMINATE COMPRISING ETHYLENE RESIN OR ETHYLENE RESIN COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2009-04-22 | — | — | EP | disclosed |
| US-20080090983-A1 | Ethylene-Based Resin and Molded Object Obtained Therefrom | MITSUI CHEMICALS, INC. (JP) | 2008-04-17 | — | — | US | disclosed |
| EP-1849805-A1 | ETHYLENIC RESIN AND FORMED ARTICLE OBTAINED THEREFROM | Mitsui Chemicals, Inc. (JP) | 2007-10-31 | — | — | EP | disclosed |
| EP-0927201-B1 | CATALYST SYSTEM FOR (CO)POLYMERIZATION OF OLEFINS AND PROCESS FOR THE PREPARATION OF OLEFIN (CO)POLYMERS USING THE CATALYST SYSTEM | HYUNDAI PETROCHEMICAL CO LTD (KR) | 2004-04-14 | — | — | EP | disclosed |
| US-5545829-A | Process for preparing cycloolefin copolymers | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-08-13 | — | — | US | disclosed |
| US-5391789-A | Bridged, chiral metallocenes, processes for their preparation and their use as catalysts | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292421-A1 | BRIDGED METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE SAME, AND ETHYLENE POLYMER OBTAINED WITH THE CATALYST | CAD, ENDOD1, CCT7 | GPR3 4863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.